CHRYSOULA KOURTIDOU-PAPADELI

Dr. CHRYSOULA KOURTIDOU-PAPADELI

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2021 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
CKCHRYSOULA KOURTIDOU-PAPADELI
CHRYSOULA KOURTIDOU-PAPADELI
CFChristos A. Frantzidis
Christos A. Frantzidis
SGSotiria Gilou
Sotiria Gilou
CPChristina E. Plomariti
Christina E. Plomariti
CNChristiane M. Nday
Christiane M. Nday
JVJoan Vernikos
Joan Vernikos
Purpose: Increasing the level of gravity passively on a centrifuge, should be equal to or even more beneficial not only to astronauts living in a microgravity environment but also to patients confined to bed. Gravity therapy (GT) may have beneficial effects on numerous conditions, such as immobility due to neuromuscular disorders, balance disorders, stroke, sports injuries. However, the appropriate configuration for administering the Gz load remains to be determined.Methods: To address these issues, we studied graded G-loads from 0.5 to 2.0g in 24 young healthy, male and female participants, trained on a short arm human centrifuge (SAHC) combined with mild activity exercise within 40–59% MHR, provided by an onboard bicycle ergometer. Hemodynamic parameters, as cardiac output (CO), stroke volume (SV), mean arterial pressure (MAP), systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR) were analyzed, as well as blood gas analysis. A one-way repeated measures ANOVA and pairwise comparisons were conducted with a level of significancep< 0.05.Results: Significant changes in heart rate variability (HRV) and its spectral components (Class, Fmax, and VHF) were found in all g loads when compared to standing (p< 0.001), except in 1.7 and 2.0g. There were significant changes in CO, cardiac index (CI), and cardiac power (CP) (p< 0.001), and in MAP (p= 0.003) at different artificial gravity (AG) levels. Dose-response curves were determined based on statistically significant changes in cardiovascular parameters, as well as in identifying the optimal G level for training, as well as the optimal G level for training. There were statistically significant gender differences in Cardiac Output/CO (p= 0.002) and Cardiac Power/CP (p= 0.016) during the AG training as compared to standing. More specifically, these cardiovascular parameters were significantly higher for male than female participants. Also, there was a statistically significant (p= 0.022) gender by experimental condition interaction, since the high-frequency parameter of the heart rate variability was attenuated during AG training as compared to standing but only for the female participants (p= 0.004).Conclusion: The comprehensive cardiovascular evaluation of the response to a range of graded AG loads, as compared to standing, in male and female subjects provides the dose-response framework that enables us to explore and validate the usefulness of the centrifuge as a medical device. It further allows its use in precisely selecting personalized gravity therapy (GT) as needed for treatment or rehabilitation of individuals confined to bed.

1 January 2020 in Acta Astronautica
Verified
Journal Article
Closed access
Christos A. FrantzidisChristos A. Frantzidis
Christos A. Frantzidis
CDChristina K. Dimitriadou
Christina K. Dimitriadou
PCPanteleimon Chriskos
Panteleimon Chriskos
SGSotiria C. Gilou
Sotiria C. Gilou
CPChristina S. Plomariti
Christina S. Plomariti
CKCHRYSOULA KOURTIDOU-PAPADELI
CHRYSOULA KOURTIDOU-PAPADELI

1 December 2021 in Sleep Medicine
Verified
Journal Article
Closed access
Athanasia PatakaAthanasia Pataka
Athanasia Pataka
Christos A. FrantzidisChristos A. Frantzidis
Christos A. Frantzidis
GKGeorge Kalamaras
George Kalamaras
PGPolyxeni Gkivogkli
Polyxeni Gkivogkli
Serafeim - Chrysovalantis KotoulasSerafeim - Chrysovalantis Kotoulas
Serafeim - Chrysovalantis Kotoulas
PANAGIOTIS BAMIDISPANAGIOTIS BAMIDIS
PANAGIOTIS BAMIDIS

13 November 2021 in High Blood Pressure & Cardiovascular Prevention
Verified
Journal Article
Closed access
PDF file
AKAgisilaos Krachtis
Agisilaos Krachtis
AKAliki Karkala
Aliki Karkala
Christos A. FrantzidisChristos A. Frantzidis
Christos A. Frantzidis
PGPolyxeni T. Gkivogkli
Polyxeni T. Gkivogkli
Aristea LadasAristea Ladas
Aristea Ladas
CKCHRYSOULA KOURTIDOU-PAPADELI
CHRYSOULA KOURTIDOU-PAPADELI

18 January 2023 in Frontiers in Physiology
Verified
Journal Article
Open access
CKCHRYSOULA KOURTIDOU-PAPADELI
CHRYSOULA KOURTIDOU-PAPADELI
CFChristos Frantzidis
Christos Frantzidis
IMIlias Machairas
Ilias Machairas
CGChristos Giantsios
Christos Giantsios
EDEmmanouil Dermitzakis
Emmanouil Dermitzakis
JVJoan Vernikos
Joan Vernikos
Introduction: The idea behind the presentation of this case relates to utilizing space technology in earth applications with mutual benefit for both patients confined to bed and astronauts. Deconditioning and the progressiveness of skeletal muscle loss in the absence of adequate gravity stimulus have been of physiological concern. A robust countermeasure to muscle disuse is still a challenge for both immobilized patients and astronauts in long duration space missions. Researchers in the space medicine field concluded that artificial gravity (AG) produced by short-radius centrifugation on a passive movement therapy device, combined with exercise, has been a robust multi-system countermeasure as it re-introduces an acceleration field and gravity load.Methods: A short-arm human centrifuge (SAHC) alone or combined with exercise was evaluated as a novel, artificial gravity device for an effective rehabilitation strategy in the case of a stroke patient with disability. The results reveal valuable information on an individualized rehabilitation strategy against physiological deconditioning. A 73-year-old woman was suddenly unable to speak, follow directions or move her left arm and leg. She could not walk, and self-care tasks required maximal assistance. Her condition was getting worse over the years, also she was receiving conventional rehabilitation treatment. Intermittent short-arm human centrifuge individualized protocols were applied for 5 months, three times a week, 60 treatments in total.Results: It resulted in significant improvement in her gait, decreased atrophy with less spasticity on the left body side, and ability to walk at least 100 m with a cane. Balance and muscle strength were improved significantly. Cardiovascular parameters improved responding to adaptations to aerobic exercise. Electroencephalography (EEG) showed brain reorganization/plasticity evidenced through functional connectivity alterations and activation in the cortical regions, especially of the precentral and postcentral gyrus. Stroke immobility-related disability was also improved.Discussion: These alterations were attributed to the short-arm human centrifuge intervention. This case study provides novel evidence supporting the use of the short-arm human centrifuge as a promising therapeutic strategy in patients with restricted mobility, with application to astronauts with long-term muscle disuse in space.

10 March 2022 in JMIR Research Protocols
Verified
Journal Article
Open access
SBSylvie Bernaerts
Sylvie Bernaerts
NWNele A J De Witte
Nele A J De Witte
VAVicky Van der Auwera
Vicky Van der Auwera
BBBert Bonroy
Bert Bonroy
LMLuiza Muraru
Luiza Muraru
Evdokimos KonstantinidisEvdokimos Konstantinidis
Evdokimos Konstantinidis
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Living labs in the health and wellbeing domain have become increasingly common over the past decade but vary in available infrastructure, implemented study designs and outcome measures. Increased transnational collaboration and harmonization can further improve research quality. The Horizon 2020 Project ‘Virtual Health and Wellbeing Living Lab Infrastructure’ (VITALISE) unites 19 partners across 11 countries. VITALISE aims to harmonize Living Lab procedures and open Living Lab Infrastructures to facilitate and promote research activities in the health and wellbeing domain in Europe and beyond. To do so, the VITALISE consortium will conduct joint research activities (JRAs) in the fields included in the care pathway of patients: rehabilitation, transitional care and everyday living environments for the elderly. In line with the expertise of the involved Living Labs, the current protocol will describe the design of the rehabilitation JRA, focusing on the use of innovative technology both for rehabilitation interventions and data collection in a rehabilitation context. Objective: With this JRA, we primarily aim to gain insight in each Living Lab’s infrastructure and procedures in order to harmonize health and wellbeing Living Lab procedures and infrastructures in Europe and beyond, in particular in the context of rehabilitation. Secondly, we aim to investigate the potential of innovative technologies for rehabilitation through Living Lab methodologies. Methods: The study has a mixed-methods design comprising multiple phases. There are two main phases of data collection, co-creation (phase 1) and small-scale pilots (phase 2), which are preceded by a preliminary harmonization of procedures between the different international Living Labs. An intermediate phase further allows to implement minor adjustments to the intervention or protocol depending on the input that was obtained in the co-creation phase. Six small-scale pilots using innovative technologies for intervention or data collection will be performed across four countries. A third and final phase involves Delphi procedures to reach consensus on harmonized procedures and protocols. Results: Phase 1 data collection will begin in March 2022 and phase 2 data collection will begin in June 2022. Results will include output of the co-creation sessions, small-scale pilots and advice on harmonizing procedures and protocols for health and wellbeing Living Labs focusing on rehabilitation. Conclusions: The knowledge gained by the execution of this research will lead to harmonized procedures and protocols in a rehabilitation context for health and wellbeing Living Labs in Europe and beyond. In addition to the harmonized procedures and protocols in rehabilitation, we will also be able to provide new insights for improving implementation of innovative technologies in rehabilitation.